- $155.36bn
- $206.74bn
- $28.19bn
- 88
- 32
- 68
- 66
REG - BkofA Merrill Lynch Horizon Therapeutics - 20230926_HORIZON THERAPEUTICS PLC_38.5 (a)_IE_MLI
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230926_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230926_HORIZON THERAPEUTICS PLC_38.5(b)_IE_BOFAS
AnnouncementREG - Adage Capital Prtnrs Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics PLC
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230925_HORIZON THERAPEUTICS PLC_38.5 (a)_IE_MLI
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230925_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230925_HORIZON THERAPEUTICS PLC_38.5(b)_IE_BOFAS
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230922_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - Adage Capital Prtnrs Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics PLC
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230921_HORIZON THERAPEUTICS PLC_38.5 (b)_BOFAS
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230921_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20230921_HORIZON THERAPEUTICS PLC_38.5 (a)_IE_MLI
AnnouncementREG - Irish Takeover Panel - Disclosure Table
AnnouncementREG - Adage Capital Prtnrs Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics PLC
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - Adage Capital Prtnrs Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics PLC
Announcement